BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2016 related articles for article (PubMed ID: 1686599)

  • 1. Molecular biology of prions causing infectious and genetic encephalopathies of humans as well as scrapie of sheep and BSE of cattle.
    Prusiner SB
    Dev Biol Stand; 1991; 75():55-74. PubMed ID: 1686599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biology and transgenetics of prion diseases.
    Prusiner SB
    Crit Rev Biochem Mol Biol; 1991; 26(5-6):397-438. PubMed ID: 1684745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prion encephalopathies of animals and humans.
    Prusiner SB
    Dev Biol Stand; 1993; 80():31-44. PubMed ID: 8270114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular biology and genetics of prion diseases.
    Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):447-63. PubMed ID: 7913765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and infectious prion diseases.
    Prusiner SB
    Arch Neurol; 1993 Nov; 50(11):1129-53. PubMed ID: 8105771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenetic studies implicate interactions between homologous PrP isoforms in scrapie prion replication.
    Prusiner SB; Scott M; Foster D; Pan KM; Groth D; Mirenda C; Torchia M; Yang SL; Serban D; Carlson GA
    Cell; 1990 Nov; 63(4):673-86. PubMed ID: 1977523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prion diseases of the central nervous system.
    Prusiner SB; DeArmond SJ
    Monogr Pathol; 1990; (32):86-122. PubMed ID: 2192281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biology of non-conventional transmissible agents or prions].
    Dormont D
    Rev Neurol (Paris); 1998 Feb; 154(2):142-51. PubMed ID: 9773035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoaffinity purification and neutralization of scrapie prions.
    Gabizon R; McKinley MP; Groth D; Westaway D; DeArmond SJ; Carlson GA; Prusiner SB
    Prog Clin Biol Res; 1989; 317():583-600. PubMed ID: 2574871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BSE: can we predict the future?
    Plum J
    Bull Mem Acad R Med Belg; 1997; 152(6):264-73. PubMed ID: 9581370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
    Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular assessment of the potential transmissibilities of BSE and scrapie to humans.
    Raymond GJ; Hope J; Kocisko DA; Priola SA; Raymond LD; Bossers A; Ironside J; Will RG; Chen SG; Petersen RB; Gambetti P; Rubenstein R; Smits MA; Lansbury PT; Caughey B
    Nature; 1997 Jul; 388(6639):285-8. PubMed ID: 9230438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmission barriers for bovine, ovine, and human prions in transgenic mice.
    Scott MR; Peretz D; Nguyen HO; Dearmond SJ; Prusiner SB
    J Virol; 2005 May; 79(9):5259-71. PubMed ID: 15827140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuropathological phenotype in transgenic mice expressing different prion protein constructs.
    DeArmond SJ; Yang SL; Cayetano-Canlas J; Groth D; Prusiner SB
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):415-23. PubMed ID: 7913760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unaltered susceptibility to BSE in transgenic mice expressing human prion protein.
    Collinge J; Palmer MS; Sidle KC; Hill AF; Gowland I; Meads J; Asante E; Bradley R; Doey LJ; Lantos PL
    Nature; 1995 Dec 21-28; 378(6559):779-83. PubMed ID: 8524411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
    Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
    J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of PrPres in BSE-infected bovine PrP transgenic mice.
    Castilla J; Gutiérrez Adán A; Brun A; Pintado B; Ramírez MA; Parra B; Doyle D; Rogers M; Salguero FJ; Sánchez C; Sánchez-Vizcaíno JM; Torres JM
    Arch Virol; 2003 Apr; 148(4):677-91. PubMed ID: 12664293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A trend of molecular genetics on prion diseases and prion protein].
    Muramatsu Y; Shinagawa M
    Nihon Rinsho; 1993 Sep; 51(9):2494-502. PubMed ID: 8411733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dominant-negative inhibition of prion replication in transgenic mice.
    Perrier V; Kaneko K; Safar J; Vergara J; Tremblay P; DeArmond SJ; Cohen FE; Prusiner SB; Wallace AC
    Proc Natl Acad Sci U S A; 2002 Oct; 99(20):13079-84. PubMed ID: 12271119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells.
    Priola SA; Caughey B; Raymond GJ; Chesebro B
    Infect Agents Dis; 1994; 3(2-3):54-8. PubMed ID: 7812655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 101.